UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option
UTI Asset Management Company Private Limited · Direct Plan · Growth
Fund overview
Nil
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,066 | +66 |
| 3 Years | ₹1,000 | ₹1,212 | +212 |
| 5 Years | ₹1,000 | ₹1,377 | +377 |
Calculated using the fund's annualised return since inception (6.6% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
50 securitiesTop 10 holdings make up 32.1% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Dixon Technologies (India) Ltd | Consumer Durables | Mid Cap | 4.56% |
| Colgate-Palmolive (India) Ltd | Personal Products | Mid Cap | 4.30% |
| BSE Ltd | Capital Markets | Large Cap | 4.24% |
| Hero Motocorp Ltd | Automobiles & Components | Mid Cap | 3.90% |
| Marico Ltd | Agricultural Food & Other Products | Mid Cap | 3.61% |
| Persistent Systems Ltd | IT - Software | Mid Cap | 3.45% |
| Page Industries Ltd | Textiles & Apparels | Mid Cap | 2.91% |
| Polycab India Ltd | Industrial Products | Large Cap | 2.61% |
| Glaxosmithkline Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 2.55% |
| Oracle Financial Services Software Ltd | IT - Software | Mid Cap | 2.50% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹249 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹249 Cr
Exit load, stamp duty & tax
11-Apr-22
Nil
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 10.57% |
| Beta | 1.00 |
| Sharpe Ratio | 2.33 |
| Sortino Ratio | -0.83 |
| Treynor Ratio | 0.25 |
| Jensen's Alpha | -0.41 |
| Information Ratio | -1.41 |
| R-Squared | 99.99% |
| Max Drawdown | -3.87% |
| Upside Capture | 98.64% |
| Downside Capture | 101.10% |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Provide Returns That, Before Expenses, Closely Correspond To The Total Returns Of The Securities As Represented By The Underlying Index, Subject To Tracking Error. However, There Is No Guarantee Or Assurance That The Investment Objective Of The Scheme Will Be Achieved.
Fund house
UTI Asset Management Company Private Limited
Frequently asked questions
What is the NAV of UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option?
The NAV of UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option is ₹13.37 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option?
The expense ratio charged by UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option is 0.69%.
What is the Min. SIP of UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option?
The minimum SIP investment in UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option is ₹500 per month.
What is the Min. Lumpsum of UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option?
The minimum lumpsum investment in UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option is ₹1,000.
What is the Exit Load of UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option?
UTI NIFTY Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option does not charge an exit load.
.svg){kind=small}